MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BRGX made $507,755 in revenue. -$73,343 in net income. Net profit margin of -14.44%.

Income Overview

Revenue
$507,755
Net Income
-$73,343
Net Profit Margin
-14.44%
Unit: Dollar
Revenue Breakdown
    • Gross sales
    • Returns (including common stock ...
Revenue Breakdown
    • Nutritional
    • Medical Testing
    • Wellness Devices
    • Other Sales
Revenue Breakdown
    • Customers And Direct Sales
    • Medical And Academic
    • Reseller

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Net sales
507,755 445,970 515,147 596,037
Cost of sales
81,358 93,514 109,116 114,389
Gross profit
426,397 352,456 406,031 481,648
Distributors incentives
2,316 2,987 8,278 10,587
Selling, general and administrative
432,540 456,728 590,368 236,279
Amortization expense
0 --562,089
Total operating expenses
434,856 459,715 598,646 808,955
Loss from operations
-8,459 -107,259 -192,615 -327,307
Interest expense and financing costs (including related party interest of 35,455 in the three months ended in march 31, 2025 and 31,063 in march 31, 2024
--74,239 67,553
Nonoperating income (expense)
----67,553
Interest expense and financing costs (including related party interest of 35,455 in the six months ended in june 30, 2025 and 31,063 in june 30, 2024
-71,086 --
Interest expense and financing costs
72,106 ---
Net loss
-80,565 -178,345 -266,854 -394,860
Foreign currency translation adjustment
7,222 -7,197 -2,059 -2,561
Other comprehensive loss
-73,343 -185,542 -268,913 -397,421
Loss per share - basic
0 0 0 0
Loss per share - diluted
0 0 0 0
Weighted average common shares outstanding - basic
960,873,144 959,205,422 956,994,100 956,530,100
Weighted average common shares outstanding - diluted
960,873,144 959,205,422 956,994,100 956,530,100
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Other comprehensiveloss-$73,343 Foreign currencytranslation adjustment$7,222 Gross sales$509,532 Net loss-$80,565 Net sales$507,755 Returns (includingcommon stock and...$1,777 Interest expense andfinancing costs$72,106 Loss from operations-$8,459 Gross profit$426,397 Cost of sales$81,358 Total operatingexpenses$434,856 Selling, general andadministrative$432,540 Distributors incentives$2,316

BIOREGENX, INC. (BRGX)

BIOREGENX, INC. (BRGX)